|1.||Tomatsu, Makoto: 3 articles (10/2014 - 09/2003)|
|2.||Tashiro, Fumio: 2 articles (10/2014 - 05/2004)|
|3.||Shibamoto, Norio: 2 articles (05/2004 - 09/2003)|
|4.||Gotoh, Yoshitaka: 1 article (10/2014)|
|5.||Komeno, Takashi: 1 article (10/2014)|
|6.||Otsuka, Hiroko: 1 article (10/2014)|
|7.||Shibagaki, Yoshio: 1 article (10/2014)|
|8.||Ono, Takahide: 1 article (10/2014)|
|9.||Iida, Naoyuki: 1 article (10/2014)|
|10.||Kawasaki, Yasushi: 1 article (10/2014)|
10/10/2014 - "Thus, these results showed that the 110-kDa HDLBP in lipid rafts acted as an aralin receptor and that its expression levels determined aralin sensitivity, suggesting that aralin could be a promising anticancer drug for HDLBP-overexpressing tumors."
10/10/2014 - "Aralin from Aralia elata is a newly identified type II ribosome- inactivating protein, which preferentially induces apoptosis in cancer cells. "
05/01/2004 - "Recently we found that aralin, a novel lectin, from Aralia elata selectively induces apoptosis in human virus-transformed and cancer cells compared with normal cells. "
09/10/2003 - "Aralin, a new cytotoxic protein from Aralia elata, inducing apoptosis in human cancer cells."
09/10/2003 - "Aralin also exhibited potent cytotoxic activity against various types of human cancer cell lines; cervical carcinoma cells (HeLa) proved the most sensitive, with an IC50 value of 0.08 ng/ml."